Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus

Journal of Diabetes

Volumn 6, Issue 4, 2014, Pages 369-377

  Galli Tsinopoulou, Assimina ^a   Maggana, Ioanna ^a   Kyrgios, Ioannis ^a   Mouzaki, Konstantina ^a   Grammatikopoulou, Maria G ^b   Stylianou, Charilaos ^a   Karavanaki, Kyriaki ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Children and adolescents; Glycemic control; Hypomagnesemia; Magnesium; Type 1 diabetes mellitus

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN A1C; INSULIN; MAGNESIUM; PHOSPHORUS; POTASSIUM; SODIUM; CREATININE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CALCIUM BLOOD LEVEL; CHILD; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR; ANALYSIS; BLOOD; COMPLICATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INFANT; MAGNESIUM; MALE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84901854875     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12118     Document Type: Article

References (68)

1. Griffin IJ. Magnesium. In: Caballero B, Trugo LC, Finglas PM (eds). Encyclopedia of Food Sciences and Nutrition, 2nd edn. Academic Press, Oxford, 2003, 3641-3646.
2. Altura BM, Altura BT. Cardiovascular risk factors and magnesium: Relationships to atherosclerosis, ischemic heart disease and hypertension. Magnes Trace Elem. 1991-1992; 10: 182-192.
3. Qu X, Jin F, Hao Y etal. Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies. PLoS ONE. 2013; 8: e57720.
4. Reffelmann T, Ittermann T, Dörr M etal. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011; 219: 280-284.
5. Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Serum magnesium concentrations in type 1 diabetic patients: Relation to early atherosclerosis. Diabetes Res Clin Pract. 2006; 72: 42-47.
6. Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol. 2012; 11: 23.
7. Sales CH, Pedrosa LdeF. Magnesium and diabetes mellitus: Their relation. Clin Nutr. 2006; 25: 554-562.
8. Simşek E, Karabay M, Kocabay K. Assessment of magnesium status in newly diagnosed diabetic children: Measurement of erythrocyte magnesium level and magnesium tolerance testing. Turk J Pediatr. 2005; 47: 132-137.
9. Tuvemo T, Ewald U, Kobbah M, Proos LA. Serum magnesium and protein concentrations during the first five years of insulin-dependent diabetes in children. Acta Paediatr Suppl. 1997; 418: 7-10.
10. Rohn RD, Pleban P, Jenkins LL. Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM. Clin Chim Acta. 1993; 215: 21-28.
11. Fort P, Lifshitz F. Magnesium status in children with insulin-dependent diabetes mellitus. J Am Coll Nutr. 1986; 5: 69-78.
12. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970; 45: 13-23.
13. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44: 291-303.
14. Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009; 4: 1832-1843.
15. Galli-Tsinopoulou A, Grammatikopoulou MG, Stylianou C, Kokka P, Emmanouilidou E. A preliminary case-control study on nutritional status, body composition, and glycemic control of Greek children and adolescents with type 1 diabetes. J Diabetes. 2009; 1: 36-42.
16. Institute of Medicine. Dietary Reference Intakes: Applications in Dietary Planning. The National Academies Press, Washington DC, 2003.
17. Rewers M, Pihoker C, Dohaghue K, Hanas R, Swift P, Klingensmith GJ. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2009; 10 (Suppl. 12): 71-81.
18. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbøl I. Renal hypomagnesaemia in human diabetes mellitus: Its relation to glucose homeostasis. Eur J Clin Invest. 1982; 12: 81-85.
19. Pham PC, Pham PM, Pham SV, Miller JM, Pham PT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007; 2: 366-373.
20. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010; 87: 261-266.
21. Lecube A, Baena-Fustegueras JA, Fort JM, Pelegrí D, Hernández C, Simó R. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS ONE. 2012; 7: e30599.
22. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012; 16: 1000-1003.
23. Viktorínová A, Toserová E, Krizko M, Duracková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism. 2009; 58: 1477-1482.
24. Sharma A, Dabla S, Agrawal RP, Barjatya H, Kochar DK, Kothari RP. Serum magnesium: An early predictor of course and complications of diabetes mellitus. J Indian Med Assoc. 2007; 105: 16, 18, 20.
25. Crook M, Couchman S, Tutt P, Amiel S, Swaminathan R. Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus. Diabetes Res. 1994; 27: 73-79.
26. Sjögren A, Florén CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand. 1988; 224: 461-466.
27. Gunn IR, Burns E. Plasma ultrafiltrable magnesium in insulin dependent diabetics. J Clin Pathol. 1987; 40: 294-297.
28. Sjögren A, Florén CH, Nilsson A. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes. 1986; 35: 459-463.
29. Johansson G, Danielson BG, Ljunghall S, Wibell L. Evidence for a disturbed magnesium metabolism in diabetes mellitus. Magnes Bull. 1981; 2: 178-180.
30. Mather HM, Nisbet JA, Burton GH etal. Hypomagnesaemia in diabetes. Clin Chim Acta. 1979; 95: 235-242.
31. Menzel R, Pusch H, Ratzmann GW etal. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test. Exp Clin Endocrinol. 1985; 85: 81-88.
32. Derakhshan R, Balaee P, Darakhshan S, Masoodpoor N, Banihosseini SS. Lipid profile, thyroid function, and serum magnesium level in type I diabetic children. Minerva Pediatr. 2011; 63: 27-33.
33. Zargar AH, Bashir MI, Masoodi SR etal. Copper, zinc and magnesium levels in type-1 diabetes mellitus. Saudi Med J. 2002; 23: 539-542.
34. Roffi M, Kanaka C, Mullis PE, Peheim E, Bianchetti MG. Hypermagnesiuria in children with newly diagnosed insulin-dependent diabetes mellitus. Am J Nephrol. 1994; 14: 201-206.
35. Walter RM Jr, Uriu-Hare JY, Olin KL etal. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care. 1991; 14: 1050-1056.
36. Husmann MJ, Fuchs P, Truttmann AC etal. Extracellular magnesium depletion in pediatric patients with insulin-dependent diabetes mellitus. Miner Electrolyte Metab. 1997; 23: 121-124.
37. Matthiesen G, Olofsson K, Rudnicki M. Ionized magnesium in Danish children with type 1 diabetes. Diabetes Care. 2004; 27: 1216-1217.
38. Corsonello A, Ientile R, Buemi M etal. Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria. Am J Nephrol. 2000; 20: 187-192.
39. Takaya J, Higashino H, Kotera F, Kobayashi Y. Intracellular magnesium of platelets in children with diabetes and obesity. Metabolism. 2003; 52: 468-471.
40. Allegra A, Corsonello A, Buemi M etal. Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria. J Trace Elem Med Biol. 1997; 11: 154-157.
41. Vanroelen WF, Van Gaal LF, Van Rooy PE, De Leeuw IH. Serum and erythrocyte magnesium levels in type I and type II diabetics. Acta Diabetol Lat. 1985; 22: 185-190.
42. Mayer-Davis EJ, Nichols M, Liese AD etal. Dietary intake among youth with diabetes: The SEARCH for Diabetes in Youth Study. J Am Diet Assoc. 2006; 106: 689-697.
43. Hypomagnesemia AF. An evidence-based approach to clinical cases. Iran J Kidney Dis. 2010; 4: 13-19.
44. Dai LJ, Ritchie G, Kerstan D, Kang HS, Cole DE, Quamme GA. Magnesium transport in the renal distal convoluted tubule. Physiol Rev. 2001; 81: 51-84.
45. Driziene Z, Stakisaitis D, Balsiene J. Magnesium urinary excretion in diabetic adolescents. Acta Med. 2005; 48: 157-161.
46. Ponder SW, Brouhard BH, Travis LB. Hyperphosphaturia and hypermagnesuria in children with IDDM. Diabetes Care. 1990; 13: 437-441.
47. Sales CH, Pedrosa LF, Lima JG, Lemos TM, Colli C. Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clin Nutr. 2011; 30: 359-364.
48. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003; 26: 1277-1294.
49. De Leeuw I, Engelen W, Vertommen J, Nonneman L. Effect of intensive i.v. + oral magnesium supplementation on circulating ion levels, lipid parameters and metabolic control in Mg-depleted insulin-dependent diabetic patients (IDDM). Magnes Res. 1997; 10: 135-141.
50. Sjögren A, Florén CH, Nilsson A. Oral administration of magnesium hydroxide to subjects with insulin-dependent diabetes mellitus: Effects on magnesium and potassium levels and on insulin requirements. Magnesium. 1988; 7: 117-122.
51. Eibl NL, Kopp HP, Nowak HR, Schnack CJ, Hopmeier PG, Schernthaner G. Hypomagnesemia in type II diabetes: Effect of a 3-month replacement therapy. Diabetes Care. 1995; 18: 188-192.
52. Gullestad L, Jacobsen T, Dolva LO. Effect of magnesium treatment on glycemic control and metabolic parameters in NIDDM patients. Diabetes Care. 1994; 17: 460-461.
53. 2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res. 2010; 23: 5-18.
54. De Valk HW, Hardus PL, van Rijn HJ, Erkelens DW. Plasma magnesium concentration and progression of retinopathy. Diabetes Care. 1999; 22: 864-865.
55. Hatwal A, Gujral AS, Bhatia RP, Agrawal JK, Bajpai HS. Association of hypomagnesemia and diabetic retinopathy. Acta Ophtalmol. 1989; 67: 714-716.
56. Ceriello A, Giugliano D, Dello Russo P, Passariello N. Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care. 1982; 5: 558-559.
57. McNair P, Christiansen C, Madsbad S etal. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes. 1978; 27: 1075-1077.
58. Corrêa ZM, Freitas AM, Marcon IM. Risk factors related to the severity of diabetic retinopathy. Arq Bras Oftalmol. 2003; 66: 739-743.
59. +-ATPase: Potential risk factors for the development of diabetic nephropathy. Pak J Pharm Sci. 2008; 21: 172-179.
60. Engelen W, Bouten A, De Leeuw I, De Block C. Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy? Magnes Res. 2000; 13: 197-203.
61. De Leeuw I, Engelen W, De Block C, Van Gaal L. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res. 2004; 17: 109-114.
62. Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther. 2007; 14: 375-385.
63. Zhou Q, Zhou Y, Liu W, Kummerow FA. Low magnesium stimulated prostacyclin generation in cultured human endothelial cells. Magnes Res. 2008; 21: 177-184.
64. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993; 21: 1024-1029.
65. Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care. 1992; 15: 835-841.
66. Bjelakovic G, Sokolovic D, Ljiljana S etal. Arginase activity and magnesium levels in blood of children with diabetes mellitus. J Basic Clin Physiol Pharmacol. 2009; 20: 319-334.
67. Ankush RD, Suryakar AN, Ankush NR. Hypomagnesaemia in type-2 diabetes mellitus patients: A study on the status of oxidative and nitrosative stress. Indian J Clin Biochem. 2009; 24: 184-189.
68. Witkowski M, Hubert J, Mazur A. Methods of assessment of magnesium status in humans: A systematic review. Magnes Res. 2011; 24: 163-180.